Cargando…
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
BACKGROUND: Cancer is a highly heterogeneous disease with varying responses to anti-cancer drugs. Although several attempts have been made to predict the anti-cancer therapeutic responses, there remains a great need to develop highly accurate prediction models of response to the anti-cancer drugs fo...
Autores principales: | Kim, Youngchul, Kim, Daewon, Cao, Biwei, Carvajal, Rodrigo, Kim, Minjung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336455/ https://www.ncbi.nlm.nih.gov/pubmed/32631229 http://dx.doi.org/10.1186/s12859-020-03633-z |
Ejemplares similares
-
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
por: Kageyama, Ken, et al.
Publicado: (2017) -
DRAP: a toolbox for drug response analysis and visualization tailored for preclinical drug testing on patient-derived xenograft models
por: Li, Quanxue, et al.
Publicado: (2019) -
Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts
por: Callari, Maurizio, et al.
Publicado: (2018) -
Are special read alignment strategies necessary and cost-effective when handling sequencing reads from patient-derived tumor xenografts?
por: Tso, Kai-Yuen, et al.
Publicado: (2014) -
Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice
por: Höfig, Ines, et al.
Publicado: (2012)